ArticleOPEN ACCESS

Correction to: Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia (PharmacoEconomics, (2018), 36, 12, (1463-1473), 10.1007/s40273-018-0709-3)

PharmacoEconomics
DOI: 10.1007/s40273-019-00809-1
1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Correction to Bounthavong M, Butler J, Dolan CM, Dunn JD, Fisher KA, Oestreicher N, Pitt B, Hauptman PJ, Veenstra DL.

Cite

CITATION STYLE

APA

Bounthavong, M., Butler, J., Dolan, C. M., Dunn, J. D., Fisher, K. A., Oestreicher, N., … Veenstra, D. L. (2019, August 1). Correction to: Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia (PharmacoEconomics, (2018), 36, 12, (1463-1473), 10.1007/s40273-018-0709-3). PharmacoEconomics. Springer International Publishing. https://doi.org/10.1007/s40273-019-00809-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free